Related references
Note: Only part of the references are listed.American society of clinical oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study
T. M. H. Niers et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Translating evidence-based guidelines into performance measures for venous thromboembolism and acute coronary syndrome
James B. Groce
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Diffuse alveolar Hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: Related and high-risk clinical syndromes
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Increased risk of venous thromboembolism in patients with acute leukaemia
M Mohren et al.
BRITISH JOURNAL OF CANCER (2006)
Thromboembolism in hospitalized neutropenic cancer patients
AA Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The risk of thrombosis in patients with acute leukemia:: occurrence of thrombosis at diagnosis and during treatment
V De Stefano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter:: A double-blind, placebo-controlled, randomized study in cancer patients
M Verso et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer
S Couban et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: A report of 7 cases
A Kazory et al.
TRANSPLANTATION (2004)
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
AK Kakkar et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness - Analysis of the MEDENOX study
R Alikhan et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Cancer and thrombosis: Mechanisms and treatment
SR Deitcher
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2003)
Hemostatic complications in bone marrow transplantation:: A retrospective analysis of 447 patients
R Pihusch et al.
TRANSPLANTATION (2002)
Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis
A Mailloux et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2001)
An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients -: The sirius study
MM Samama
ARCHIVES OF INTERNAL MEDICINE (2000)
Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
